Funds and ETFs Guobang Pharma Ltd.

Equities

605507

CNE100004NS2

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-05-09 pm EDT 5-day change 1st Jan Change
17.45 CNY -2.19% Intraday chart for Guobang Pharma Ltd. +4.74% -0.63%

ETFs positioned on Guobang Pharma Ltd.

Name Weight AuM 1st Jan change Investor Rating
0.00% 0 M€ +3.63% -
Guobang Pharma Ltd is a China-based company mainly engaged in the research and development, production, and sales of related products in the field of medicine and animal health products. The Company's pharmaceutical business includes raw materials, key pharmaceutical intermediates and preparations, and its main products include azithromycin, clarithromycin, and roxithromycin cephalosporin series products. The animal health products business includes animal protection raw materials, animal protection additives and preparations. The main products of veterinary antibiotics include florfenicol, enrofloxacin series, etc., and insecticides include diclazuril and cypronamine, and reparation products include premixes, powders, granules, etc.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
17.45 CNY
Average target price
24 CNY
Spread / Average Target
+37.54%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 605507 Stock
  4. Funds and ETFs Guobang Pharma Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW